Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac36278fe42aa93b8f741c6b88b2848b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-64 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68 |
filingDate |
2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215f13ae6c4e9a00fba81e21773776de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56aab00bea61feafb5e36846f6c5dcc4 |
publicationDate |
2009-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-550250-A |
titleOfInvention |
Recombinantly modifed plasminogen |
abstract |
Polynucleotides and polypeptides relating to a recombinantly-modified human plasminogen molecule are provided. The plasminogen molecule has a single kringle domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme. |
priorityDate |
2004-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |